Cited by 293Immunodeficiency and Autoimmune DisordersPsoriasis: Treatment and PathogenesisT-cell and B-cell Immunology

An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis

Open access
Boisson, Bertrand, Wang, Chenhui, Pedergnana, Vincent, Wu, Ling, Cypowyj, Sophie, Rybojad, Michel, Belkadi, Aziz, Picard, Capucine +5 more·2013·Immunity

Abstract

Patients with inborn errors of interleukin-17F (IL-17F) or IL-17RA display chronic mucocutaneous candidiasis (CMC). We report a biallelic missense mutation (T536I) in the adaptor molecule ACT1 in two siblings with CMC. The mutation, located in the SEFIR domain, abolished the homotypic interaction of ACT1 with IL-17 receptors, with no effect on homodimerization. The patients' fibroblasts failed to respond to IL-17A and IL-17F, and their T cells to IL-17E. By contrast, healthy individuals homozygous for the common variant D10N, located in the ACT1 tumor necrosis factor receptor-associated factor-interacting domain and previously associated with psoriasis, had impaired, but not abolished, responses to IL-17 cytokines. SEFIR-independent interactions of ACT1 with other proteins, such as CD40, heat shock protein 70 (HSP70) and HSP90, were not affected by the T536I mutation. Overall, human IL-17A and IL-17F depend on ACT1 to mediate protective mucocutaneous immunity. Moreover, other ACT1-dependent IL-17 cytokines seem to be largely redundant in host defense.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2013.09.002

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL-17 receptor signaling plays an indispensable role in mucocutaneous host defense against fungi in mice and humans.

    “IL-17 receptor (IL-17R) signaling is well-recognized to play an indispensable role in mucocutaneous host defense against fungi (including Candida species) in mice and humans (Boisson et al., 2013; Conti et al., 2016; Lionakis and Levitz, 2018; Puel et al., 2011).”

    From Murine model of colonization with fungal pathogen Candida auris to explore skin tropism, host risk factors and therapeutic strategies (2021) · cites this paper as Boisson et al., 2013

    The Introduction (page unavailable) states that IL-17A and IL-17F are essential for protective mucocutaneous immunity to C. albicans in humans, and reports chronic mucocutaneous candidiasis in patients with impaired IL-17 signaling. The Discussion mentions IL-17 signaling in mice, but its mouse infection examples concern bacteria and worms, not mucocutaneous fungal defense. The claim’s extension to mice is therefore not supported by this paper’s text. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 63

  1. Abecasis GR Cherny SS Cookson WO Cardon LR 2002 Merlin--rapid analysis of dense genetic maps using sparse gene flow trees Nat Genet 30 97 101 11731797
  2. Adzhubei I Jordan DM Sunyaev SR 2013 Predicting Functional Effect of Human Missense Mutations Using PolyPhen-2 Curr Protoc Hum Genet Chapter 7 Unit 7 20 23315928 PMC4480630
  3. Atkinson TP Schaffer AA Grimbacher B Schroeder HW Jr Woellner C Zerbe CS Puck JM 2001 An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family Am J Hum Genet 69 791 803 11517424 PMC1226065
  4. Bieber T 2008 Atopic dermatitis N Engl J Med 358 1483 1494 18385500
  5. Bogunovic D Byun M Durfee LA Abhyankar A Sanal O Mansouri D Salem S Radovanovic I Grant AV Adimi P 2012 Mycobacterial Disease and Impaired IFN-gamma Immunity in Humans with Inherited ISG15 Deficiency Science PMC3507439 22859821
  6. Boisson B Laplantine E Prando C Giliani S Israelsson E Xu Z Abhyankar A Israel L Trevejo-Nunez G Bogunovic D 2012 Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency Nat Immunol 13 1178 1186 23104095 PMC3514453
  7. Bolze A Byun M McDonald D Morgan NV Abhyankar A Premkumar L Puel A Bacon CM Rieux-Laucat F Pang K 2010 Whole-exome-sequencing-based discovery of human FADD deficiency Am J Hum Genet 87 873 881 21109225 PMC2997374
  8. Byun M Abhyankar A Lelarge V Plancoulaine S Palanduz A Telhan L Boisson B Picard C Dewell S Zhao C 2010 Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma J Exp Med 207 2307 2312 20876309 PMC2964585
  9. Canales L Middlemas RO 3rd Louro JM South MA 1969 Immunological observations in chronic mucocutaneous candidiasis Lancet 2 567 571 4185535
  10. Chandesris MO Melki I Natividad A Puel A Fieschi C Yun L Thumerelle C Oksenhendler E Boutboul D Thomas C 2012 Autosomal Dominant STAT3 Deficiency and Hyper-IgE Syndrome: Molecular, Cellular, and Clinical Features From a French National Survey Medicine (Baltimore) 91 e1 e19 22751495 PMC3680355
  11. Chang SH Park H Dong C 2006 Act1 adaptor protein is an immediate and essential signaling component of interleukin-17 receptor J Biol Chem 281 35603 35607 17035243
  12. Chang SH Reynolds JM Pappu BP Chen G Martinez GJ Dong C 2011 Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E Immunity 35 611 621 21982598 PMC5800502
  13. Claudio E Sonder SU Saret S Carvalho G Ramalingam TR Wynn TA Chariot A Garcia-Perganeda A Leonardi A Paun A 2009 The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation J Immunol 182 1617 1630 19155511 PMC2630122
  14. de Beaucoudrey L Puel A Filipe-Santos O Cobat A Ghandil P Chrabieh M Feinberg J von Bernuth H Samarina A Janniere L 2008 Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells J Exp Med 205 1543 1550 18591412 PMC2442631
  15. de Beaucoudrey L Samarina A Bustamante J Cobat A Boisson-Dupuis S Feinberg J Al-Muhsen S Janniere L Rose Y de Suremain M 2010 Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries Medicine (Baltimore) 89 381 402 21057261 PMC3129625
  16. Drewniak A Gazendam RP Tool AT van Houdt M Jansen MH van Hamme JL van Leeuwen EM Roos D Scalais E de Beaufort C 2013 Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency Blood 121 2385 2392 23335372
  17. Ellinghaus E Ellinghaus D Stuart PE Nair RP Debrus S Raelson JV Belouchi M Fournier H Reinhard C Ding J 2010 Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 Nat Genet 42 991 995 20953188 PMC3136364
  18. Fallon PG Ballantyne SJ Mangan NE Barlow JL Dasvarma A Hewett DR McIlgorm A Jolin HE McKenzie AN 2006 Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion J Exp Med 203 1105 1116 16606668 PMC2118283
  19. Glocker E Grimbacher B 2010 Chronic mucocutaneous candidiasis and congenital susceptibility to Candida Curr Opin Allergy Clin Immunol 10 542 550 20859203
  20. Hori T Ohnishi H Teramoto T Tsubouchi K Naiki T Hirose Y Ohara O Seishima M Kaneko H Fukao T Kondo N 2012 Autosomal-Dominant Chronic Mucocutaneous Candidiasis with STAT1-Mutation can be Complicated with Chronic Active Hepatitis and Hypothyroidism J Clin Immunol 22847544
  21. Huffmeier U Uebe S Ekici AB Bowes J Giardina E Korendowych E Juneblad K Apel M McManus R Ho P 2010 Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis Nat Genet 42 996 999 20953186 PMC2981079
  22. Kalliomaki M Salminen S Arvilommi H Kero P Koskinen P Isolauri E 2001 Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial Lancet 357 1076 1079 11297958
  23. Kang Z Swaidani S Yin W Wang C Barlow JL Gulen MF Bulek K Do JS Aronica M McKenzie AN 2012 Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin(−)c-Kit(+) innate cell population Immunity 36 821 833 22608496 PMC3376903
  24. Kirkpatrick CH Rich RR Graw RG Jr Smith TK Mickenberg I Rogentine GN 1971 Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution Clin Exp Immunol 9 733 748 4945734 PMC1713127
  25. Kisand K Boe Wolff AS Podkrajsek KT Tserel L Link M Kisand KV Ersvaer E Perheentupa J Erichsen MM Bratanic N 2010 Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines J Exp Med 207 299 308 20123959 PMC2822605
  26. Lanternier F Pathan S Vincent Q Liu L Cypowyj S Prando C Migaud M Taibi L Ammar-Khodja A Boudghene Stambouli O 2013 Human deep dermatophytosis and inherited CARD9 deficiency New England Journal of Medecine In press PMC4084693 24131138
  27. Leroy D Dompmartin A Houtteville JP Theron J 1989 Aneurysm associated with chronic mucocutaneous candidiasis during long-term therapy with ketoconazole Dermatologica 178 43 46 2492956
  28. Li H Durbin R 2009 Fast and accurate short read alignment with Burrows-Wheeler transform Bioinformatics 25 1754 1760 19451168 PMC2705234
  29. Li H Handsaker B Wysoker A Fennell T Ruan J Homer N Marth G Abecasis G Durbin R 2009 The Sequence Alignment/Map format and SAMtools Bioinformatics 25 2078 2079 19505943 PMC2723002
  30. Lilic D 2012 Unravelling fungal immunity through primary immune deficiencies Curr Opin Microbiol 15 420 426 22818901
  31. Liu C Swaidani S Qian W Kang Z Sun P Han Y Wang C Gulen MF Yin W Zhang C 2011a A CC’ loop decoy peptide blocks the interaction between Act1 and IL-17RA to attenuate IL-17- and IL-25-induced inflammation Sci Signal 4 ra72 22045852 PMC3282585
  32. Liu L Okada S Kong XF Kreins AY Cypowyj S Abhyankar A Toubiana J Itan Y Audry M Nitschke P 2011b Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis J Exp Med 208 1635 1648 21727188 PMC3149226
  33. Ma CS Chew GY Simpson N Priyadarshi A Wong M Grimbacher B Fulcher DA Tangye SG Cook MC 2008 Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 J Exp Med 205 1551 1557 18591410 PMC2442632
  34. Matsushima Y Kikkawa Y Takada T Matsuoka K Seki Y Yoshida H Minegishi Y Karasuyama H Yonekawa H 2010 An atopic dermatitis-like skin disease with hyper-IgE-emia develops in mice carrying a spontaneous recessive point mutation in the Traf3ip2 (Act1/CIKS) gene J Immunol 185 2340 2349 20660351
  35. Mauro C Vito P Mellone S Pacifico F Chariot A Formisano S Leonardi A 2003 Role of the adaptor protein CIKS in the activation of the IKK complex Biochem Biophys Res Commun 309 84 90 12943667
  36. McKenna A Hanna M Banks E Sivachenko A Cibulskis K Kernytsky A Garimella K Altshuler D Gabriel S Daly M DePristo MA 2010 The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data Genome Res 20 1297 1303 20644199 PMC2928508
  37. Mellett M Atzei P Horgan A Hams E Floss T Wurst W Fallon PG Moynagh PN 2012 Orphan receptor IL-17RD tunes IL-17A signalling and is required for neutrophilia Nat Commun 3 1119 23047677
  38. Milner JD Brenchley JM Laurence A Freeman AF Hill BJ Elias KM Kanno Y Spalding C Elloumi HZ Paulson ML 2008 Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome Nature 452 773 776 18337720 PMC2864108
  39. Minegishi Y Saito M Nagasawa M Takada H Hara T Tsuchiya S Agematsu K Yamada M Kawamura N Ariga T 2009 Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome J Exp Med 206 1291 1301 19487419 PMC2715068
  40. Ng PC Henikoff S 2003 SIFT: Predicting amino acid changes that affect protein function Nucleic Acids Res 31 3812 3814 12824425 PMC168916
  41. Onishi RM Gaffen SL 2010 Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease Immunology 129 311 321 20409152 PMC2826676
  42. Owyang AM Zaph C Wilson EH Guild KJ McClanahan T Miller HR Cua DJ Goldschmidt M Hunter CA Kastelein RA Artis D 2006 Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract J Exp Med 203 843 849 16606667 PMC1800834
  43. Prando C Samarina A Bustamante J Boisson-Dupuis S Cobat A Picard C Alsum Z Al-Jumaah S Al-Hajjar S Frayha H 2013 Inherited IL-12p40 Deficiency: Genetic, Immunologic, and Clinical Features of 49 Patients From 30 Kindreds Medicine (Baltimore) 92 109 122 23429356 PMC3822760
  44. Puel A Cypowyj S Marodi L Abel L Picard C Casanova JL 2012 Inborn errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis Curr Opin Allergy Clin Immunol 12 616 622 23026768 PMC3538358
  45. Puel A Doffinger R Natividad A Chrabieh M Barcenas-Morales G Picard C Cobat A Ouachee-Chardin M Toulon A Bustamante J 2010 Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I J Exp Med 207 291 297 20123958 PMC2822614
  46. Qian Y Giltiay N Xiao J Wang Y Tian J Han S Scott M Carter R Jorgensen TN Li X 2008 Deficiency of Act1, a critical modulator of B cell function, leads to development of Sjogren’s syndrome Eur J Immunol 38 2219 2228 18624351 PMC3225253
  47. Qian Y Liu C Hartupee J Altuntas CZ Gulen MF Jane-Wit D Xiao J Lu Y Giltiay N Liu J 2007 The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease Nat Immunol 8 247 256 17277779
  48. Qian Y Qin J Cui G Naramura M Snow EC Ware CF Fairchild RL Omori SA Rickert RC Scott M 2004 Act1, a negative regulator in CD40- and BAFF-mediated B cell survival Immunity 21 575 587 15485634
  49. Renner ED Rylaarsdam S Anover-Sombke S Rack AL Reichenbach J Carey JC Zhu Q Jansson AF Barboza J Schimke LF 2008 Novel signal transducer and activator of transcription 3 (STAT3) mutations, reduced T(H)17 cell numbers, and variably defective STAT3 phosphorylation in hyper-IgE syndrome J Allergy Clin Immunol 122 181 187 18602572 PMC4560358
  50. Rickel EA Siegel LA Yoon BR Rottman JB Kugler DG Swart DA Anders PM Tocker JE Comeau MR Budelsky AL 2008 Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities J Immunol 181 4299 4310 18768888
  51. Romberg N Morbach H Lawrence MG Kim S Kang I Holland SM Milner JD Meffre E 2013 Gain-of-function STAT1 mutations are associated with PD-L1 overexpression and a defect in B-cell survival J Allergy Clin Immunol PMC3672340 23403048
  52. Sampaio EP Hsu AP Pechacek J Bax HI Dias DL Paulson ML Chandrasekaran P Rosen LB Carvalho DS Ding L 2013 Signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations and disseminated coccidioidomycosis and histoplasmosis J Allergy Clin Immunol 131 1624 1634 e1617 23541320 PMC3746066
  53. Smeekens SP Plantinga TS van de Veerdonk FL Heinhuis B Hoischen A Joosten LA Arkwright PD Gennery A Kullberg BJ Veltman JA 2011 STAT1 hyperphosphorylation and defective IL12R/IL23R signaling underlie defective immunity in autosomal dominant chronic mucocutaneous candidiasis PLoS One 6 e29248 22195034 PMC3237610
  54. Takezaki S Yamada M Kato M Park MJ Maruyama K Yamazaki Y Chida N Ohara O Kobayashi I Ariga T 2012 Chronic mucocutaneous candidiasis caused by a gain-of-function mutation in the STAT1 DNA-binding domain J Immunol 189 1521 1526 22730530
  55. Uzel G Sampaio EP Lawrence MG Hsu AP Hackett M Dorsey MJ Noel RJ Verbsky JW Freeman AF Janssen E 2013 Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome J Allergy Clin Immunol 131 1611 1623 e1613 23534974 PMC3672257
  56. van de Veerdonk FL Plantinga TS Hoischen A Smeekens SP Joosten LA Gilissen C Arts P Rosentul DC Carmichael AJ Smits-van der Graaf CA 2011 STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis N Engl J Med 365 54 61 21714643
  57. Wang C Wu L Bulek K Martin BN Zepp JA Kang Z Liu C Herjan T Misra S Carman JA 2013a The psoriasis-associated D10N variant of the adaptor Act1 with impaired regulation by the molecular chaperone hsp90 Nat Immunol 14 72 81 23202271 PMC3522792
  58. Wang X Lin Z Gao L Wang A Wan Z Chen W Yang Y Li R 2013b Exome sequencing reveals a signal transducer and activator of transcription 1 (STAT1) mutation in a child with recalcitrant cutaneous fusariosis J Allergy Clin Immunol 131 1242 1243 23245795
  59. Wells RS 1970 Chronic oral candidiasis (autosomal recessive inheritance) (three cases) Proc R Soc Med 63 890 891 5477064 PMC1812166
  60. Wells RS Higgs JM Macdonald A Valdimarsson H Holt PJ 1972 Familial chronic muco-cutaneous candidiasis J Med Genet 9 302 310 4562433 PMC1469124
  61. Williamson DM 1969 Chronic hyperplastic candidiasis and squamous carcinoma Br J Dermatol 81 125 127 5767066
  62. Zhang B Liu C Qian W Han Y Li X Deng J 2013 Crystal Structure of IL-17 Receptor B SEFIR Domain J Immunol PMC3578156 23355738
  63. Zhao A Urban JF Jr Sun R Stiltz J Morimoto M Notari L Madden KB Yang Z Grinchuk V Ramalingam TR 2010 Critical role of IL-25 in nematode infection-induced alterations in intestinal function J Immunol 185 6921 6929 20974983 PMC2988083

Cited by

Sorted by citations

Authors
Boisson, B., Wang, C., Pedergnana, V., Wu, L., Cypowyj, S., Rybojad, M., Belkadi, A., Picard, C., Abel, L., Fieschi, C., Puel, A., Li, X., & Casanova, J.-L.
Affiliations
  • Rockefeller University (US)
  • Cleveland Clinic (US)
  • Inserm (FR)
  • Hôpital Saint-Louis (FR)
  • Hôpital Necker-Enfants Malades (FR)
Corresponding author
  • Boisson, Bertrand
  • Casanova, Jean-Laurent
Venue
Immunity
Publisher
Elsevier BV
Published
2013-10
Volume
39
Issue
4
Pages
676-686
ISSN
1074-7613 (ISSN-L)
OpenAlex
W1998541797
Cited by
293
References
11
Citations by year
2026: 9 · 2025: 16 · 2024: 8 · 2023: 23 · 2022: 17 · 2021: 34 · 2020: 35 · 2019: 19 · 2018: 21 · 2017: 31 · 2016: 25 · 2015: 29 · 2014: 22 · 2013: 3
FWCI
14.58
Type
journal article
Language
en
Open access
Locations
  • Immunity (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • HAL (submittedVersion)
Funders
  • St. Giles Foundation
  • AXA Research Fund
  • National Institutes of Health (UL1TR000043, 1r01ns071996-01a1, UL1TR000004)
  • National Institute of General Medical Sciences (T32GM007250)
  • National Institute of Allergy and Infectious Diseases (T32AI089474)
  • National Institute of Neurological Disorders and Stroke (R01-NS071996)
  • National Center for Research Resources
  • National Center for Advancing Translational Sciences (8UL1TR00004)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
Act1, chronic mucocutaneous candidiasis, IL-17, IL-17F, IL-17A, IL-25, missense mutations, IL-17 receptor signaling, T cell response, fibroblast response, CD40, HSP70, HSP90, cytokine redundancy, primary immunodeficiency
MeSH terms
Adult, Amino Acid Sequence, Candidiasis, Chronic Mucocutaneous, Female, Fibroblasts, Heat-Shock Proteins, Homozygote, Humans, Immunity, Innate, Male, Molecular Sequence Data, Pedigree, T-Lymphocytes, Protein Structure, Tertiary, Immunity, Mucosal, CD40 Antigens, Mutation, Missense, Interleukin-17, Siblings, Tumor Necrosis Factor Receptor-Associated Peptides and Proteins, Adaptor Proteins, Signal Transducing, Receptors, Interleukin-17, Protein Multimerization

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review